520 related articles for article (PubMed ID: 9920167)
41. Prolongation of the prothrombin time and activated partial thromboplastin time in children with sickle cell disease.
Raffini LJ; Niebanck AE; Hrusovsky J; Stevens A; Blackwood-Chirchir A; Ohene-Frempong K; Kwiatkowski JL
Pediatr Blood Cancer; 2006 Oct; 47(5):589-93. PubMed ID: 16123995
[TBL] [Abstract][Full Text] [Related]
42. [Investigation of coagulation time: PT and APTT].
Ramakers C; van der Heul C; van Wijk EM
Ned Tijdschr Geneeskd; 2012; 156(0):A3985. PubMed ID: 22917038
[TBL] [Abstract][Full Text] [Related]
43. Assessment of Stability of Prothrombin Time, International Normalized Ratio, and Activated Partial Thromboplastin Time Under Different Storage Conditions in Human Plasma.
Patil P; Sehgal T; Goswami P; Gaur M; Khan M; Pandey S; Datta SK
Cureus; 2022 Jan; 14(1):e21268. PubMed ID: 35178322
[TBL] [Abstract][Full Text] [Related]
44. Coagulation abnormalities in patients with chronic liver disease in Pakistan.
Siddiqui SA; Ahmed M; Ghani MH; Memon MA; Mustafa G; Ghori MA
J Pak Med Assoc; 2011 Apr; 61(4):363-7. PubMed ID: 21465974
[TBL] [Abstract][Full Text] [Related]
45. Emergency Coagulation Assessment During Treatment With Direct Oral Anticoagulants: Limitations and Solutions.
Ebner M; Birschmann I; Peter A; Härtig F; Spencer C; Kuhn J; Blumenstock G; Zuern CS; Ziemann U; Poli S
Stroke; 2017 Sep; 48(9):2457-2463. PubMed ID: 28775134
[TBL] [Abstract][Full Text] [Related]
46. Do PT and APTT sensitivities to factors' deficiencies calculated by the H47-A2 2008 CLSI guideline reflect the deficiencies found in plasmas from patients?
Martinuzzo M; Barrera L; Rodriguez M; D'Adamo MA; López MS; Otaso JC
Int J Lab Hematol; 2015 Dec; 37(6):853-60. PubMed ID: 26338156
[TBL] [Abstract][Full Text] [Related]
47. Laboratory diagnosis of bleeding disorders. Basic screening tests.
Palmer RL
Postgrad Med; 1984 Dec; 76(8):137-42, 147-8. PubMed ID: 6334288
[TBL] [Abstract][Full Text] [Related]
48. Comparison of thromboelastometry (ROTEM®) with standard plasmatic coagulation testing in paediatric surgery.
Haas T; Spielmann N; Mauch J; Madjdpour C; Speer O; Schmugge M; Weiss M
Br J Anaesth; 2012 Jan; 108(1):36-41. PubMed ID: 22086509
[TBL] [Abstract][Full Text] [Related]
49. Activated Partial Thromboplastin Time and Prothrombin Time Mixing Studies: Current State of the Art.
Adcock DM; Moore GW; Montalvão SL; Kershaw G; Gosselin RC
Semin Thromb Hemost; 2023 Sep; 49(6):571-579. PubMed ID: 36055261
[TBL] [Abstract][Full Text] [Related]
50. Laboratory coagulation parameters in extremely premature infants born earlier than 27 gestational weeks upon admission to a neonatal intensive care unit.
Neary E; Okafor I; Al-Awaysheh F; Kirkham C; Sheehan K; Mooney C; Foran A; Corcoran JD; Ni Ainle F; Cotter M; McCallion N
Neonatology; 2013; 104(3):222-7. PubMed ID: 24030102
[TBL] [Abstract][Full Text] [Related]
51. Effect of lipoprotein-associated coagulation inhibitor (LACI) on thromboplastin-induced coagulation of normal and hemophiliac plasmas.
Welsch DJ; Novotny WF; Wun TC
Thromb Res; 1991 Oct; 64(2):213-22. PubMed ID: 1811340
[TBL] [Abstract][Full Text] [Related]
52. Intraoperative measurement of activated partial thromboplastin time and prothrombin time by a portable laser photometer in patients following cardiopulmonary bypass.
Nuttall GA; Oliver WC; Beynen FM; Dull JJ; Murray MJ; Nichols WL
J Cardiothorac Vasc Anesth; 1993 Aug; 7(4):402-9. PubMed ID: 8400094
[TBL] [Abstract][Full Text] [Related]
53. Evaluation of a bench-top coagulation analyzer for measurement of prothrombin time, activated partial thromboplastin time, and fibrinogen concentrations in healthy dogs.
Mineo HK; Garabed RB
Am J Vet Res; 2007 Dec; 68(12):1342-7. PubMed ID: 18052739
[TBL] [Abstract][Full Text] [Related]
54. Thromboelastometry as an Alternative Method for Coagulation Assessment in Pediatric Patients Undergoing Invasive Procedures: A Pilot Study.
Durila M; Jonas J; Durilova M; Rygl M; Skrivan J; Vymazal T
Eur J Pediatr Surg; 2019 Jun; 29(3):298-301. PubMed ID: 30068007
[TBL] [Abstract][Full Text] [Related]
55. The effects of inaccurate blood sample volume on prothrombin time (PT) and activated partial thromboplastin time (aPTT).
Peterson P; Gottfried EL
Thromb Haemost; 1982 Apr; 47(2):101-3. PubMed ID: 7101228
[TBL] [Abstract][Full Text] [Related]
56. Comparability of the results of PT-INR with local MNPT and APTTR with MNAPTT on different coagulation analyzers in China.
Peng L; Yan C; Wu X; Nie L
Int J Lab Hematol; 2009 Jun; 31(3):352-8. PubMed ID: 18510575
[TBL] [Abstract][Full Text] [Related]
57. [Monitoring of coagulation status in the physician's laboratory].
Marbet GA
Ther Umsch; 1995 May; 52(5):343-9. PubMed ID: 7770821
[TBL] [Abstract][Full Text] [Related]
58. How to report results of prothrombin and activated partial thromboplastin times.
Tripodi A; Lippi G; Plebani M
Clin Chem Lab Med; 2016 Feb; 54(2):215-22. PubMed ID: 26351955
[TBL] [Abstract][Full Text] [Related]
59. Effect of freezing plasma at -20°C for 2 weeks on prothrombin time, activated partial thromboplastin time, dilute Russell viper venom time, activated protein C resistance, and D-dimer levels.
Foshat M; Bates S; Russo W; Huerta A; Albright K; Giddings K; Indrikovs A; Qian YW
Clin Appl Thromb Hemost; 2015 Jan; 21(1):41-7. PubMed ID: 24842886
[TBL] [Abstract][Full Text] [Related]
60. Evaluation of a point-of-care coagulation analyzer (Abaxis VSPro) for identification of coagulopathies in dogs.
Dixon-Jimenez AC; Brainard BM; Cathcart CJ; Koenig A
J Vet Emerg Crit Care (San Antonio); 2013; 23(4):402-7. PubMed ID: 23796019
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
